Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-κB ligand

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4360-4368

  Mochizuki, Ayako ^a   Takami, Masamichi ^a   Kawawa, Tadaharu ^a   Suzumoto, Reina ^a   Sasaki, Takahisa ^a   Shiba, Akihiko ^a   Tsukasaki, Hiroaki ^a   Zhao, Baohong ^a   Yasuhara, Rika ^a   Suzawa, Tetsuo ^a   Miyamoto, Yoichi ^a   Choi, Yongwon ^b   Kamijo, Ryutaro ^a  

^a SHOWA UNIVERSITY   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL STIMULATION; CONTROLLED STUDY; CULTURE VESSEL; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; MACROPHAGE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; PHAGOCYTOSIS; PRIORITY JOURNAL; STEM CELL;

EID: 33749138412     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4360     Document Type: Article

References (57)

1. Chambers, T. J. 2000. Regulation of the differentiation and function of osteoclasts. J. Pathol. 192: 4-13.
2. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357.
3. Takahashi, N., T. Akatsu, N. Udagawa, T. Sasaki, A. Yamaguchi, J. M. Moseley, T. J. Martin, and T. Suda. 1988. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123: 2600-2602.
4. Wong, B. R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F. S. Bartlett III, W. N. Frankel, et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272: 25190-25194.
5. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. C. Dougall, M. E. Tometsko, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
6. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
7. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95: 3597-3602.
8. Darnay, B. G., V. Haridas, J. Ni, P. A. Moore, and B. B. Aggarwal. 1998. Characterization of the intracellular domain of receptor activator of NF-κB (RANK): interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J. Biol. Chem. 273: 20551-20555.
9. Hsu, H., D. L. Lacey, C. R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H. L. Tan, G. Elliott, M. J. Kelley, I. Sarosi, et al. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96: 3540-3545.
10. Mizukami, J., G. Takaesu, H. Akatsuka, H. Sakurai, J. Ninomiya-Tsuji, K. Matsumoto, and N. Sakurai. 2002. Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol. Cell. Biol. 22: 992-1000.
11. Matsumoto, M., T. Sudo, T. Saito, H. Osada, and M. Tsujimoto. 2000. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL). J. Biol. Chem. 275: 31155-31161.
12. Jimi, E., S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi, and T. Suda. 1999. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163: 434-442.
13. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
14. Grigoriadis, A. E., Z. Q. Wang, M. G. Cecchini, W. Hofstetter, R. Felix, H. A. Fleisch, and E. F. Wagner. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448.
15. Iotsova, V., J. Caamano, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-KB2. Nat. Med. 3: 1285-1289.
16. Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, et al. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12: 1260-1268.
17. Mizuno, A., N. Amizuka, K. Irie, A. Murakami, N. Fujise, T. Kanno, Y. Sato, N. Nakagawa, H. Yasuda, S. Mochizuki, et al. 1998. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun. 247: 610-615.
18. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
19. Moreno, J. L., M. Kaczmarek, A. D. Keegan, and M. Tondravi. 2003. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 102: 1078-1086.
20. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
21. Udagawa, N., N. J. Horwood, J. Elliott, A. Mackay, J. Owens, H. Okamura, M. Kurimoto, T. J. Chambers, T. J. Martin, and M. T. Gillespie. 1997. Interleukin-18 interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation. J. Exp. Med. 185: 1005-1012.
22. Jimi, E., I. Nakamura, L. T. Duong, T. Ikebe, N. Takahashi, G. A. Rodan, and T. Suda. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247: 84-93.
23. 2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells. J. Bone Miner. Res. 7: 555-561.
24. Wani, M. R., K. Fuller, N. S. Kim, Y. Choi, and T. Chambers. 1999. Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140: 1927-1935.
25. Kaneda, T., T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. Mano, M. Kumegawa, and Y. Hakeda. 2000. Endogenous production of TGF-β is essential for osteoclastogenesis induced by a combination of receptor activator of NF-κB ligand and macrophage-colony-stimulating factor. J. Immunol. 165: 4254-4263.
26. 1 in osteoclast differentiation and survival. J. Cell Sci. 113: 2445-2453.
27. Sells Galvin, R. J., C. L. Gatlin, J. W. Horn, and T. R. Fuson. 1999. TGF-β enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem. Biophys. Res. Commun. 265: 233-239.
28. Kobayashi, K., N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, et al. 2000. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191: 275-286.
29. Takeshita, S., K. Kaji, and A. Kudo. 2000. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15: 1477-1488.
30. Takami, M., N. Kim, J. Rho, and Y. Choi. 2002. Stimulation by Toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169: 1516-1523.
31. Kahn, A. J., and D. J. Simmons. 1975. Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue. Nature 258: 325-327.
32. Walker, D. G. 1975. Control of bone resorption by hematopoietic tissue: the induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants. J. Exp. Med. 142: 651-663.
33. Udagawa, N., N. Takahashi, T. Akatsu, H. Tanaka, T. Sasaki, T. Nishihara, T. Koga, T. J. Martin, and T. Suda. 1990. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA 87: 7260-7264.
34. Arai, F., T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D. M. Anderson, and T. Suda. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fras and receptor activator of nuclear factor κB (RANK) receptors. J. Exp. Med. 190: 1741-1754.
35. Li, X., N. Udagawa, M. Takami, N. Sato, Y. Kobayashi, and N. Takahashi. 2003. p38 mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology 144: 4999-5005.
36. Wong, B. R., R. Josien, and Y. Choi. 1999. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J. Leukocyte Biol. 65: 715-724.
37. Yan, T., B. L. Riggs, W. J. Boyle, and S. Khosla. 2001. Regulation of osteoclastogenesis and RANK expression by TGF-β1. J. Cell. Biochem. 83: 320-325.
38. Quinn, J. M., K. Itoh, N. Udagawa, K. Hausler, H. Yasuda, N. Shima, A. Mizuno, K. Higashio, N. Takahashi, T. Suda, et al. 2001. Transforming growth factor β affects osteoclast differentiation via direct and indirect actions. J. Bone Miner. Res. 16: 1787-1794.
39. Massey, H. M., J. Scopes, M. A. Horton, and A. M. Flanagan. 2001. Transforming growth factor-β1 (TGF-β) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone 28: 577-582.
40. Kanazawa, K., and A. Kudo. 2005. TRAF2 is essential for TNF-α-induced osteoclastogenesis. J. Bone Miner. Res. 20: 840-847.
41. Miyamoto, T., F. Arai, O. Ohneda, K. Takagi, D. M. Anderson, and T. Suda. 2000. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand. Blood 96: 4335-4343.
42. Yamaguchi, Y., H. Tsumura, M. Miwa, and K. Inaba. 1997. Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15: 144-153.
43. Lacey, D. L., J. M. Erdmann, S. L. Teitelbaum, H. L. Tan, J. Ohara, and A. Shioi. 1995. Interleukin 4, interferon-γ, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 136: 2367-2376.
44. Huang, W., R. J. O'Keefe, and E. M. Schwarz. 2003. Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-γ by inducing terminal differentiation. Arthritis Res. Ther. 5: R49-R59.
45. Lacey, D. L., H. L. Tan, J. Lu, S. Kaufman, G. Van, W. Qiu, A. Rattan, S. Scully, F. Fletcher, T. Juan, et al. 2000. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am. J. Pathol. 157: 435-448.
46. Akatsu, T., T. Murakami, M. Nishikawa, K. Ono, N. Shinomiya, E. Tsuda, S. Mochizuki, K. Yamaguchi, M. Kinosaki, K. Higashio, et al. 1998. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem. Biophys. Res. Commun. 250: 229-234.
47. Abu-Amer, Y., F. P. Ross, J. Edwards, and S. L. Teitelbaum. 1997. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin. Invest. 100: 1557-1565.
48. Nair, S. P., S. Meghji, M. Wilson, K. Reddi, P. White, and B. Henderson. 1996. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64: 2371-2380.
49. 5 is expressed on avian osteoclast precursors and regulated by retinoic acid. J. Bone Miner. Res. 14: 32-38.
50. 3 integrin subunits in rat osteoclasts in situ. J. Bone Miner. Res. 8: 403-414.
51. Zou, W., and Z. Bar-Shavit. 2002. Dual modulation of osteoclast differentiation by lipopolysaccharide. J. Bone Miner. Res. 17: 1211-1218.
52. Ishida, M., and S. Amano. 2004. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. J. Bone Miner. Metab. 22: 415-429.
53. Rivollier, A., M. Mazzorana, J. Tebib, M. Piperno, T. Aitsiselmi, C. Rabourdin-Combe, P. Jurdic, and C. Servet-Delprat. 2004. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104: 4029-4037.
54. Kim, N., Y. Kadono, M. Takami, J. Lee, S. H. Lee, F. Okada, J. H. Kim, T. Kobayashi, P. R. Odgren, H. Nakano, et al. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202: 589-595.
55. Miyamoto, T., O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D. M. Anderson, and T. Suda. 2001. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
56. Ikeda, F., R. Nishimura, T. Matsubara, S. Tanaka, J. Inoue, S. V. Reddy, K. Hata, K. Yamashita, T. Hiraga, T. Watanabe, et al. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114: 475-484.
57. Matsuo, K., D. L. Galson, C. Zhao, L. Peng, C. Laplace, K. Z. Wang, M. A. Bachler, H. Amano, H. Aburatani, H. Ishikawa, and E. F. Wagner. 2004. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279: 26475-26480.